BioSyent (CVE:RX) Reaches New 12-Month High – Here’s What Happened

BioSyent Inc. (CVE:RX)’s share price reached a new 52-week high on Monday . The stock traded as high as C$11.74 and last traded at C$11.74, with a volume of 4577 shares traded. The stock had previously closed at C$11.25.

BioSyent Price Performance

The company has a current ratio of 6.13, a quick ratio of 6.91 and a debt-to-equity ratio of 3.19. The company has a market cap of C$135.60 million, a PE ratio of 19.50 and a beta of 0.93. The firm has a 50 day moving average of C$11.05 and a two-hundred day moving average of C$10.27.

BioSyent (CVE:RX) last released its quarterly earnings data on Monday, August 26th. The company reported C$0.13 earnings per share (EPS) for the quarter, meeting the consensus estimate of C$0.13. The business had revenue of C$8.95 million for the quarter, compared to analysts’ expectations of C$8.80 million. BioSyent had a return on equity of 20.88% and a net margin of 21.14%. Research analysts predict that BioSyent Inc. will post 0.6944444 earnings per share for the current fiscal year.

Insider Activity at BioSyent

In other news, insider FAX Capital Corp. sold 230,800 shares of the stock in a transaction on Friday, November 22nd. The stock was sold at an average price of C$11.12, for a total transaction of C$2,566,496.00. Also, Director Seyed Ahmad Ashrafi sold 2,320 shares of the stock in a transaction on Friday, September 20th. The shares were sold at an average price of C$10.95, for a total value of C$25,404.00. In the last three months, insiders have sold 233,720 shares of company stock valued at $2,598,560. 33.65% of the stock is owned by corporate insiders.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.